跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 108,193 条关于
“Programmed Cell Death Ligand 1”
全部
108,193
临床试验
72,183
药物
11,507
机构
1,525
资讯
22,978
2年前
Optimizing Outcomes for High-Risk, Non-Muscle-Invasive Bladder Cancer with PD-(L)1 Inhibitors
去年
AstraZeneca's Durvalumab Receives Indian Approval for Expanded NSCLC Treatment
2年前
Low Incidence of Cardiovascular Events with Immune Checkpoint Inhibitors Reported in Meta-Analysis
8天前
Immunotherapy, Not Chemotherapy, Drives Hair Repigmentation in Thoracic Cancer Patients
5个月前
AP Biosciences and Tasly Amend Collaboration to Accelerate Global Development of Dual-Target Cancer Therapy AP505
2年前
Endometrial Cancer Clinical Trial Landscape Shows Increasing Global Activity
去年
BNT113 Cancer Vaccine Shows Promise in Phase II/III Trial for HPV16+ Head and Neck Cancer
去年
Rakuten Medical Secures AMED Funding for Novel PD-L1 Photoimmunotherapy RM-0256
去年
BioNTech's BNT113 mRNA Cancer Vaccine Advances in Phase 2 Trial for HPV+ Head and Neck Cancer
去年
Exelixis Initiates Phase 1 Trial of XB628, a Novel Bispecific NK Cell Engager for Advanced Solid Tumors
第 1 页，共 2298 页
上一页
下一页
